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Research in Alzheimer disease has recently demonstratedcompelling evidence on the importance of oxidative processes in its patho-
genesis. Cellular changes show that oxidative stress is an event that precedes the appearance of the hallmark pathologies of the dis-
ease, neuroﬁbrillary tangles, and senile plaques. While it is still unclear what the initial source of the oxidative stress is in Alzheimer
disease, it is likely that the process is highly dependent on redox-active transition metals such as iron and copper. Further investiga-
tion into the role that oxidative stress mechanisms seem to play in the pathogenesis of Alzheimer disease may lead to novel clinical
interventions.
INTRODUCTION
Much of the research performed on Alzheimer disease
(AD) over the past decade has focused on oxidative stress
mechanisms and its importance in disease pathogenesis.
Multiple lines of evidence have implicated oxidative stress
and free radical damage to the pathogenesis and possible eti-
ology of AD.
The net eﬀect of oxygen radicals is damage. Such damage
f o u n di nA Di n c l u d e sa d v a n c e dg l y c a t i o ne n dp r o d u c t s[ 1],
nitration [2], lipid peroxidation adduction products [3, 4]
as well as carbonyl-modiﬁed neuroﬁlament protein and free
carbonyls [5, 6]. Importantly, this damage involves all neu-
rons vulnerable to death in AD, not just those containing
neuroﬁbrillary tangles. In fact, the spatio-temporal distribu-
tion of speciﬁc types of damage elegantly reﬂects the biology
and chemistry of each modiﬁcation.
The cytopathological signiﬁcance of oxidative damage
is seen by the up-regulation of antioxidant enzymes. Heme
oxygenase-1 (HO-1) is among the most sensitive and selec-
tive indicators of the cellular oxidative stress response and, in
AD, we demonstrated that both HO-1 protein and its mRNA
are increased in brains of AD patients [7, 8]. In later stud-
ies, we demonstrated that increased HO-1 expression co-
localizes with the altered form of tau (τ)[ 9].
OXIDATIVE STRESS AND NFT MODIFICATION
There is much substantive evidence for progressive ox-
idative modiﬁcation of proteins as a consequence of aging.
However, the most crucial aspects of the cellular oxidative
damage in AD pathogenesis appear to be the cytoskeletal
modiﬁcations in neurons susceptible to AD, which in turn
play a key role in the irreversible cellular dysfunction that
ultimately leads to neuronal death [10]. The most obvious
of these cytoskeletal abnormalities are the NFT, which are
arguably the most important aspect of the degenerating phe-
notypeinAD-aﬀectedneurons.Theseinclusionslargelycon-
sist of modiﬁed medium and high molecular weight neu-
roﬁlaments (NFM and NFH, respectively) as well as the
microtubule-stabilizing protein τ. In NFT, these two families
of protein have an abnormally high level of phosphorylation,
which may be explained by their conserved kinase consensus
sequences [11]. In addition to hyperphosphorylation, pro-
teins in both NFT and senile plaques have been shown to be
modiﬁed by the addition of advanced glycation endproducts
(AGE) [1] and hydroxynonenal [4].
Some of the antibodies used to detect NFT speciﬁcally
recognize oxidation-dependent epitopes. We have demon-
strated that two antibodies to NFT recognize carbonyl-
modiﬁed epitopes of high molecular weight neuroﬁlaments
(NFH) [6]. Although both of these antibodies recognized
neuroﬁlaments of the axon in aldehyde-ﬁxed sections, they
demonstrated no reactivity in immunoblots with normal ax-
onal protein prepared from tissue unexposed to ﬁxatives.
In contrast, if these immunoblots were carbonyl-modiﬁed,
both antibodies recognized NFH. Signiﬁcantly, in samples
from AD brains, the antibodies recognized NFT epitopes in
both tissue sections and NFT-derived NFH in immunoblots
without need of carbonyl modiﬁcation. Sporadic lesion-
related immunoreactivity was seen in control patients. Fur-
thermore, carbonyl-modiﬁed NFTs could be isolated from
homogenates of AD brain tissue but not from control tissue.
Taken together, these results suggest that oxidized NFH is a
prominent antigen in NFT [6].
The oxidative conversion of protein side-chains to re-
active carbonyl or acylating moieties, or adduction of bi-
functional sugar- or lipid-derived products can result in ab-
normal protein cross-linking. Both neuroﬁlaments and τ
can form noncovalent aggregates in the absence of oxida-
tion. However, they have a limited lifetime, and the protein-
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or other molecules if no suitably reactive and/or positioned
group is nearby. We hypothesize that the pathogenic role of
oxidative stress, involving direct oxidation and/or modiﬁca-
tion by oxidation, may be primarily in the covalent “cement-
ing” of reversible associations normally reﬂecting simple
noncovalent aﬃnities. It has been found that many proteins
associatedwithNFTareapparentlycovalentlycross-linkedto
the ﬁlaments since they cannot be removed by denaturants.
This is consistent with other studies, which show that oxida-
tive covalent cross-linking of proteins occur predominantly
when the proteins are preassociated. The in vitro enzymatic
cross-linkingoftaucouldbeproducedonlywhentheprotein
substrates were properly associated. Since oxidation-based
cross-linking reduces susceptibility to proteolytic degrada-
tion by providing nonpeptide bonds [12], covalent cross-
linking may in fact represent a neurotoxic event by inhibit-
ingturnover.Simultaneously,severaloxidativemodiﬁcations
may generate chemical species, which themselves support
further oxidative stress through “redox cycling” or transition
metal sequestration.
HOW OXIDATIVE DAMAGE COMPARES TEMPORALLY
TO LESIONS OF ALZHEIMER DISEASE
Closer examination of the spatio-temporal relationship
between the presence of oxidative modiﬁcation and the hall-
mark AD lesions reveals an apparent paradox. It has been
foundthatwhilestableglycationproductsarepredominantly
associated with NFT and amyloid-β (Aβ)d e p o s i t s[ 1], re-
versible or rapidly degraded adduction products are primar-
ily in the cytoplasm of vulnerable neurons. This data means
that oxidative damage is not restricted to long-lived lesions.
In fact, when damage to short-lived molecules is examined,
thedamageisrestrictedtocytosoliccompartmentswithNFT
and Aβ being inversely correlated.
To address where reactive oxygen species are produced,
we focused our eﬀorts to ﬁnding a marker that results from
primary attack, rather than more complex secondary reac-
tions, and which involves damage to a cell constituent with a
shorthalf-life.Proteinsfailinthelatteraspectofthesecriteria
because cross-link modiﬁcations slow their turnover. There-
fore, modiﬁcations associated with cross-linking of proteins,
while useful to assess history, may reveal less of the current
state. However, 8-hydroxyguanosine (8OHG), a nucleic acid
modiﬁcation predominantly derived from hydroxide (•OH)
attack of guanidine, is ampliﬁed in cytoplasmic RNA in vul-
nerableneuronalpopulations[13].Notably,casesofADwith
the most extensive Aβ deposits show the lowest 8OHG levels.
These ﬁndings seem markedly contradictory if we consider
Aβ to be the toxic agent in AD, which is likewise proposed to
be a major source of oxidative free radicals [14]. However,
neurons containing NFT also have extremely low levels of
8OHG (ie, current oxidative stress status) despite an obvious
historyofoxidativedamage(ie,advancedglycationendprod-
ucts or lipid peroxidation). This suggests that both Aβ and
NFT may serve an antioxidant function, and thus be cellular
compensations for increased oxidative stress. The hypothesis
that Aβ plays an antioxidant function is supported by a study
of Down syndrome patients, a disease where Aβ deposits be-
gin in the late teens and in which oxidative stress has been
implicated [15].
MITOCHONDRIAL ABNORMALITIES: THE MAIN
SOURCE OF OXIDATIVE IMBALANCE?
Mitochondria are a potential major source of oxida-
tive radicals and oxidative precursors, in the form of O−
2
and H2O2, respectively, since their production is linked to
metabolism. In early studies, we found increases in mito-
chondrial DNA in the cell soma of AD susceptible neurons,
whichinitselfmightcauseincreasedoxidativepotential.Per-
haps more importantly, in situ hybridization studies with a
chimericcDNAprobetoacommonmitochondrialmutation
(5 kilobase (kb) common deletion) have shown at least a 3-
fold increase in AD cases compared to controls. Ultrastruc-
tural localization of mtDNA with colloidal gold shows that
deleted mtDNA is mainly found in abnormal mitochondria
(ie, those lacking cristae, swollen and in many cases fused
with lipofuscin). These ﬁndings suggest that the mtDNA in
situ hybridization detected mtDNA proliferation, deletion,
and duplication in abnormal mitochondria, many of which
have been fused with lysosomes, indicating that they are be-
ing turned over.
Quantitative analysis of the colocalization of the mtDNA
deletion and 8OHG in AD cases demonstrate a strong posi-
tive correlation (r = 0.934). However, mitochondrial DNA,
even that containing the 5kb deletion, is relatively spared
fromoxidativedamage,liketheformationof8OHG,incom-
parison to cytoplasmic nucleic acid (ie, RNA). We therefore
suspect that mitochondrial abnormalities correlate with, but
do not directly cause, reactive oxygen species (ROS). This
may be due to the fact that hydroxide radicals, which are re-
sponsible for the formation of 8OHG, have a sphere of diﬀu-
sion of only 2nm and are fairly short lived. Therefore, since
damageistopographicallydistinct,itislikelythatOHradical
formationoccursinthecytoplasmratherthanthemitochon-
dria and that they are unable to diﬀuse through the mito-
chondrial membrane to aﬀect mtDNA. However, abnormal
mitochondria may produce excess H2O2 through the conver-
sion of O−
2 by mitochondrial superoxide dismutase (SOD).
Such H2O2 is readily diﬀusible and relatively stable, that is,
until interacting with redox-active transition metals where
the Fenton reaction produces hydroxyl radicals.
REDOX-ACTIVE METALS IN ALZHEIMER DISEASE:
PROXIMAL MARKERS OF OXIDATIVE STRESS?
Several studies have implicated imbalances of trace ele-
ments, including Al, Si, Pb, Hg, Zn, Cu, and Fe in AD. A
disruption in the homeostasis of the latter two redox-active
metals is particularly signiﬁcant in light of the increases in
oxidative stress parameters, such as lipid peroxidation, and
the oxidative damage to NFTs, senile plaques [1, 2, 4], and
nucleic acids [13].122 George Perry et al 2:3 (2002)
Micro particle-induced x-ray emission, recently found
that Zn(II), Fe(III), and Cu(II) are signiﬁcantly increased in
AD neuropil and that these metals are more concentrated
within the core and periphery of senile plaques [16]. These
results support earlier studies reporting increased levels of
iron, transferrin, and ferritin in AD. An in situ iron detection
methodrevealedasigniﬁcantassociationofredox-activeiron
with both NFT and senile plaques (SP) in AD. The associa-
tion of iron with NFT may be partly related to the binding of
iron to τ, their primary protein constituent [17].
Recent histochemical studies have demonstrated that the
directdetectionofredoxactivityinADlesionsisinhibitedby
prior exposure of tissue sections to copper and iron selective
chelators [4]. Re-exposure of the chelator-treated sections to
either copper or iron salts can reinstate activity, suggesting
that redox imbalance in AD is dependent on these metals. It
is therefore probable that accumulation of iron and copper is
a major source of the production of ROS, which are in turn
responsible for the more global oxidative stress parameters
observed in AD.
Free iron has been implicated in undergoing redox tran-
sitions in vivo with the consequent generation of oxygen free
radicals more than any other transition metal. Abnormally
high levels of iron and oxidative stress have been shown in a
number of neurodegenerative disorders including AD [18],
Parkinson disease (PD), multiple system atrophy, and pro-
gressive supranuclear palsy. However, oxidative stress is usu-
ally associated with increased free iron. Therefore, experi-
mental ﬁndings of increased total iron do not necessarily im-
plicate increased oxidative stress if there are concomitant in-
creases in proteins that store iron in redox inert forms. For
example, ferritin (which can be over-expressed in PD and
AD) complexes iron in its core to produce the insoluble, un-
reactive compound ferrihydrate.
CONCLUSION
The fact that oxidative stress plays an important role
in AD pathogenesis is apparent, given all the evidence the
research has recently provided. Markers of oxidative dam-
age including heme oxygenase-1 (HO-1) and 8OHG are in-
creased in the AD brain as compared with controls. In addi-
tion, NFTs and senile plaques are altered in ways character-
istic of oxidative damage including AGE-modiﬁcation, pro-
tein cross-linking and carbonyl- and acyl-modiﬁcation. Al-
though the source of the shift in oxidative homeostasis is
still unclear, current evidence points to changes in the bal-
ance of redox transition metals, especially iron and copper.
Both Fe and Cu are present at signiﬁcantly elevated levels in
AD neuropil, and detection of redox activity in the AD brain
can be attenuated by chelators of these key metals. It has also
been demonstrated that many of the proteins that are impor-
tantintheirregulation,includingferritinandceruloplasmin,
show altered expression in AD and other neurodegenerative
disorders. These changes could be responsible for the oxida-
tiveimbalanceormayrepresentanattemptedantioxidantre-
sponse by aﬀected cells.
However,thekeyaspectofthedegreeofcognitive decline
in neurodegenerative disease is selective neuronal death. Our
ﬁndings that neurons displaying protein damage indicate an
oxidative stress response is still in need of a mechanism that
links damage and death. Determining the relative contribu-
tion of sugar- or lipid-adduction reactions as well as direct
side-chainoxidationtothepropertiesofabnormalinclusions
will provide insight into the mechanistic link, but also into
rational therapeutic protocols for each disease, for example,
using water- versus lipid-soluble antioxidants or free-radical
versus carbonyl scavengers. We are encouraged by the pre-
liminary epidemiological and clinical studies suggesting that
inhibiting oxidative stress and glycation are eﬀective in re-
ducing the clinical manifestation of neurodegenerative dis-
eases [19]. The stage is now set to critically examine the im-
portance of oxidative imbalance in the pathogenesis of AD
as antioxidants, and chelating agents take a primary role in
clinical intervention of neurodegenerative diseases.
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